» Articles » PMID: 29698402

A New Method for Evaluating Tumor-infiltrating Lymphocytes (TILs) in Colorectal Cancer Using Hematoxylin and Eosin (H-E)-stained Tumor Sections

Overview
Journal PLoS One
Date 2018 Apr 27
PMID 29698402
Citations 26
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Numerous reports indicate that tumor-infiltrating lymphocytes (TILs) are a prognostic factor in various cancers and that they must be good biomarkers. However, the methods of evaluating TILs differ in each study; thus, there is not yet a standardized methodology for evaluating TILs. The purpose of this study is to evaluate the prognostic significance of tumor-infiltrating lymphocytes (TILs) in patients with colorectal cancer (CRC) using the new method proposed by the International TILs Working Group in breast cancer and to standardize the method of evaluating TILs in CRC.

Methods: We retrospectively reviewed a database of 160 patients with Stage II or III CRC. The density of TILs was assessed by measuring the area occupied by mononuclear cells over the stromal area on hematoxylin and eosin (H-E)-stained sections. We set 42% as the cut-off percentage of the area occupied by TILs according to the receiver operating characteristic curve, and we classified patients into the high-TILs and the low-TILs groups.

Results: The rates of relapse-free survival (RFS) and overall survival (OS) in the high-TILs group were significantly higher than those in the low-TILs group. A multivariate analysis showed that the density of TILs was independently associated with RFS and OS. Moreover, the density of TILs assessed by an observer was significantly associated with the density of TILs assessed by the automated imaging software program.

Conclusions: The new method for evaluating TILs, which was recommended by the International TILs Working Group in breast cancer, might be a useful predictive factor in colorectal cancer patients.

Citing Articles

Integrative analysis of H&E and IHC identifies prognostic immune subtypes in HPV related oropharyngeal cancer.

Nakkireddy S, Jang I, Kim M, Yin L, Rivera M, Garcia J Commun Med (Lond). 2024; 4(1):190.

PMID: 39363031 PMC: 11450009. DOI: 10.1038/s43856-024-00604-w.


Tumor Microenvironment-Based Risk Stratification of Oropharyngeal Squamous Cell Carcinoma.

Almangush A, Jouhi L, Haglund C, Hagstrom J, Makitie A, Leivo I Head Neck. 2024; 47(2):599-605.

PMID: 39340223 PMC: 11717971. DOI: 10.1002/hed.27945.


Role of Tumor-Infiltrating Lymphocytes and the Tumor Microenvironment in the Survival of Malignant Parotid Gland Tumors: A Two-Centre Retrospective Analysis of 107 Patients.

De Luca P, Stadio A, Petruzzi G, Mazzola F, Fior M, de Campora L J Clin Med. 2024; 13(12).

PMID: 38930103 PMC: 11204737. DOI: 10.3390/jcm13123574.


High tumour-infiltrating lymphocytes correlate with distinct gene expression profile and favourable survival in single hormone receptor-positive breast cancer.

Ciarka A, Kunc M, Popeda M, Lacko A, Radecka B, Braun M Contemp Oncol (Pozn). 2024; 28(1):75-83.

PMID: 38800535 PMC: 11117162. DOI: 10.5114/wo.2024.139375.


Colorectal Carcinomas: Searching for New Histological Parameters Associated with Lymph Node Metastases.

Jurescu A, Vaduva A, Vita O, Gheju A, Cornea R, Lazureanu C Medicina (Kaunas). 2023; 59(10).

PMID: 37893479 PMC: 10608479. DOI: 10.3390/medicina59101761.


References
1.
Pages F, Berger A, Camus M, Sanchez-Cabo F, Costes A, Molidor R . Effector memory T cells, early metastasis, and survival in colorectal cancer. N Engl J Med. 2005; 353(25):2654-66. DOI: 10.1056/NEJMoa051424. View

2.
Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G . The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014. Ann Oncol. 2014; 26(2):259-71. PMC: 6267863. DOI: 10.1093/annonc/mdu450. View

3.
Mei Z, Liu Y, Liu C, Cui A, Liang Z, Wang G . Tumour-infiltrating inflammation and prognosis in colorectal cancer: systematic review and meta-analysis. Br J Cancer. 2014; 110(6):1595-605. PMC: 3960618. DOI: 10.1038/bjc.2014.46. View

4.
Huh J, Lee J, Kim H . Prognostic significance of tumor-infiltrating lymphocytes for patients with colorectal cancer. Arch Surg. 2012; 147(4):366-72. DOI: 10.1001/archsurg.2012.35. View

5.
Swisher S, Wu Y, Castaneda C, Lyons G, Yang F, Tapia C . Interobserver Agreement Between Pathologists Assessing Tumor-Infiltrating Lymphocytes (TILs) in Breast Cancer Using Methodology Proposed by the International TILs Working Group. Ann Surg Oncol. 2016; 23(7):2242-8. DOI: 10.1245/s10434-016-5173-8. View